{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:32:08Z","timestamp":1775701928973,"version":"3.50.1"},"reference-count":30,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,1,30]]},"DOI":"10.1536\/ihj.20-537","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T22:13:35Z","timestamp":1611958415000},"page":"197-200","source":"Crossref","is-referenced-by-count":7,"title":["Electron Microscopy Revealed Massive Lipid Droplets in Cardiomyocytes in a Patient with Cardiogenic Shock Following a Fulminant Type 1 Diabetes Mellitus"],"prefix":"10.1536","volume":"62","author":[{"given":"Ryosuke","family":"Sugawara","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Okayama Saiseikai General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Okayama Saiseikai General Hospital"},{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Tohgi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Sakakibara Heart Institute of Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hongo","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Okayama Saiseikai General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Okayama Saiseikai General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriya","family":"Momoki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Okayama Saiseikai General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Nose","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama Saiseikai General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikao","family":"Yutani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Amagasaki Chuo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Okayama Saiseikai General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 2000; 342: 301-7.","DOI":"10.1056\/NEJM200002033420501"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hiramatsu S, Komori K, Mori E, Ogo A, Maruyama S, Kato S. A case of fulminant type 1 diabetes mellitus accompanied by myocarditis. Endocr J 2011; 58: 553-7.","DOI":"10.1507\/endocrj.K11E-007"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Makino K, Nishimae I, Suzuki N, <i>et al<\/i>. Myocarditis with fulminant type 1 diabetes mellitus diagnosed by cardiovascular magnetic resonance imaging: a case report. BMC Res Notes 2013; 6: 347.","DOI":"10.1186\/1756-0500-6-347"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ohara N, Kaneko M, Kuwano H, <i>et al<\/i>. Fulminant type 1 diabetes mellitus and fulminant viral myocarditis. A case report and literature review. Int Heart J 2015; 56: 239-44.","DOI":"10.1536\/ihj.14-250"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mokuno T, Sawai Y, Oda N, <i>et al<\/i>. A case of myocarditis associated with IDDM. Diabetes Care 1996; 19: 374-8.","DOI":"10.2337\/diacare.19.4.374"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yoneda S, Imagawa A, Fukui K, <i>et al<\/i>. A Histological Study of Fulminant Type 1 Diabetes Mellitus Related to Human Cytomegalovirus Reactivation. J Clin Endocrinol Metab 2017; 102: 2394-400.","DOI":"10.1210\/jc.2016-4029"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007; 115: 3213-23.","DOI":"10.1161\/CIRCULATIONAHA.106.679597"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 2002; 105: 1727-33.","DOI":"10.1161\/01.CIR.0000012466.50373.E8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 2002; 105: 1861-70.","DOI":"10.1161\/01.CIR.0000012467.61045.87"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. McGavock JM, Lingvay I, Zib I, <i>et al<\/i>. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007; 116: 1170-5.","DOI":"10.1161\/CIRCULATIONAHA.106.645614"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ruberg FL. Myocardial lipid accumulation in the diabetic heart. Circulation 2007; 116: 1110-2.","DOI":"10.1161\/CIRCULATIONAHA.107.721860"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shimabukuro M. Cardiac adiposity and global cardiometabolic risk: new concept and clinical implication. Circ J 2009; 73: 27-34.","DOI":"10.1253\/circj.CJ-08-1012"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sharma S, Adrogue JV, Golfman L, <i>et al<\/i>. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004; 18: 1692-700.","DOI":"10.1096\/fj.04-2263com"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Toth PP, Raghavan VA. Glucolipotoxicity and the heart. Heart Fail Clin 2012; 8: xvii-xviii.","DOI":"10.1016\/j.hfc.2012.07.001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nakanishi T, Kato S. Impact of diabetes mellitus on myocardial lipid deposition: an autopsy study. Pathol Res Pract 2014; 210: 1018-25.","DOI":"10.1016\/j.prp.2014.04.008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hirano K, Ikeda Y, Zaima N, Sakata Y, Matsumiya G. Triglyceride deposit cardiomyovasculopathy. N Engl J Med 2008; 359: 2396-8.","DOI":"10.1056\/NEJMc0805305"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hirano K. A novel clinical entity: triglyceride deposit cardiomyovasculopathy. J Atheroscler Thromb 2009; 16: 702-5.","DOI":"10.5551\/jat.1669"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Haemmerle G, Lass A, Zimmermann R, <i>et al<\/i>. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-7.","DOI":"10.1126\/science.1123965"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Zimmermann R, Strauss JG, Haemmerle G, <i>et al<\/i>. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004; 306: 1383-6.","DOI":"10.1126\/science.1100747"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Takagi A, Ikeda Y, Kobayashi K, <i>et al<\/i>. Newly developed selective immunoinactivation assay revealed reduction in adipose triglyceride lipase activity in peripheral leucocytes from patients with idiopathic triglyceride deposit cardiomyovasculopathy. Biochem Biophys Res Commun 2018; 495: 646-51.","DOI":"10.1016\/j.bbrc.2017.11.070"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ikeda Y, Hirano K, Fukushima N, Sawa Y. A novel type of human spontaneous coronary atherosclerosis with triglyceride deposition. Eur Heart J 2014; 35: 875.","DOI":"10.1093\/eurheartj\/eht522"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Jia G, Hill MA, Sowers JR. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. Circ Res 2018; 122: 624-38.","DOI":"10.1161\/CIRCRESAHA.117.311586"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab 2012; 15: 805-12.","DOI":"10.1016\/j.cmet.2012.04.006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest 2000; 105: 1723-30.","DOI":"10.1172\/JCI9056"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-9.","DOI":"10.1016\/S0140-6736(63)91500-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Czech MP, Corvera S. Signaling mechanisms that regulate glucose transport. J Biol Chem 1999; 274: 1865-8.","DOI":"10.1074\/jbc.274.4.1865"},{"key":"27","unstructured":"27. Rosen P, Du X, Tschope D. Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol? Mol Cell Biochem 1998; 188: 103-11."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Roduit R, Morin J, Masse F, <i>et al<\/i>. Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta -cell. J Biol Chem 2000; 275: 35799-806.","DOI":"10.1074\/jbc.M006001200"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Leone TC, Weinheimer CJ, Kelly DP. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 1999; 96: 7473-8.","DOI":"10.1073\/pnas.96.13.7473"},{"key":"30","unstructured":"30. Mair J, Lindahl B, Hammarsten O, <i>et al<\/i>. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care 2018; 7: 553-60."}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-537\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T03:58:58Z","timestamp":1611979138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-537\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-537","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}